Today’s special
Cyclospora scare cost Cava 150 basis points as Q3 comps slow to 3.1%
Cava's Q3 comps slowed to 3.1% as cyclospora fears cost it 150 basis points, yet revenue rose 22.1% to $353.7M and full-year guidance was raised to 6-7%.
Topic
Topic
Today’s special

Cava's Q3 comps slowed to 3.1% as cyclospora fears cost it 150 basis points, yet revenue rose 22.1% to $353.7M and full-year guidance was raised to 6-7%.
We use cookies for analytics and site preferences. Choose what to allow. Cookie policy